Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuroimaging in substance abuse disorders].

A de Mendelssohn1, S Kasper, J Tauscher

  • 1Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie Wien.

Der Nervenarzt
|August 10, 2004
PubMed
Summary

Neuroimaging techniques like SPECT, PET, fMRI, and MRS have significantly advanced the understanding of substance abuse disorders, revealing crucial pathophysiological and neuropsychological insights. These methods illuminate the brain

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fruquintinib in combination with tislelizumab versus trifluridine/tipiracil and bevacizumab in third-line and beyond MSS mCRC without active liver metastases-the IKF-080/AIO-QUINTIS trial.

ESMO gastrointestinal oncology·2026
Same author

Virtual reality support during systemic cancer therapy to improve anxiety/depressive symptoms and reduce toxicity in patients with gastrointestinal cancers-OncoVR.

ESMO gastrointestinal oncology·2026
Same author

TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.

ESMO gastrointestinal oncology·2026
Same author

Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trial.

ESMO gastrointestinal oncology·2026
Same author

Human <i>in vivo</i> assessment of ketamine binding of the serotonin transporter-follow up at a higher dose.

Frontiers in neuroscience·2025
Same author

Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.

ESMO open·2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Radiology

Background:

  • Substance abuse disorders involve complex pathophysiological and neuropsychological mechanisms.
  • Early neuroimaging focused on structural changes like cerebral atrophy.
  • Advancements necessitate exploring functional imaging for deeper insights.

Purpose of the Study:

  • To discuss the influence of neuroimaging techniques on understanding substance abuse disorders.
  • To review exemplary findings and areas of scientific interest.
  • To highlight the role of functional imaging in characterizing substance abuse.

Main Methods:

  • Review of structural neuroimaging techniques (e.g., CT, MRI).
  • Analysis of functional neuroimaging techniques including SPECT, PET, fMRI, and MRS.
  • Examination of research findings related to substance abuse disorders.

Main Results:

  • Functional neuroimaging (SPECT, PET, fMRI, MRS) offers broader research capabilities than structural imaging.
  • These techniques characterize abused substance pharmacology and pathophysiology.
  • Neuroimaging reveals neuropsychiatric underpinnings and changes in cerebral metabolism.

Conclusions:

  • Neuroimaging is pivotal in advancing the understanding of substance abuse disorders.
  • Functional techniques provide critical insights into brain function and metabolism in addiction.
  • Continued research using these methods is essential for developing effective treatments.

Related Experiment Videos